GlaxoSmithKline debuts DTC campaign for Shingrix amid COVID-19-related vaccination dive

หน้าแรก / News / GlaxoSmithKline debuts DTC campaign for Shingrix amid COVID-19-related vaccination dive

https://www.fiercepharma.com/marketing/glaxosmithkline-debuts-dtc-campaign-for-shingrix-amid-covd-related-vaccination-dive

Recent News

Covid-19 vaccine update: Bharat Biotech’s Covaxin to undergo trial in Bangladesh? All you need to know

Bhopal Hospital’s Serious Breach of Covaxin Trial Protocols Could Prove Costly

Indian state asks govt to stop sending Covaxin vaccine doses as it won’t use them until efficacy data published

Vaccination reaches 2nd leg but Covaxin yet to gain acceptance

Ocugen and Bharat Biotech Announce Execution of Definitive Agreement for the Commercialization of Covaxin in the US Market

เกี่ยวกับเรา

In 1993, Biogenetech started with just 10 staff, distributing diagnostic kits and nuclear medicines.
In the past 25 years, Biogenetech introduced more than 15 innovative vaccines and pharmaceuticals, contributing to the improvements in public health standards in Thailand, protecting our population from numerous infectious diseases!

อ่านเพิ่มเติม